Maggu

Based in Brazil, Maggu provides innovative artificial intelligence solutions tailored for pharmacies, enhancing staff interaction at the counter and improving customer service efficiency. Maggu operates as a technology provider focused on the pharmacy sector, headquartered in Sao Paulo, Brazil. The company was founded in 2023 by Felipe Trevisan and Luiz Andrade, with co-founders Pedro Magela, Reslley Gabriel, and Rérica Lins Ghirelli, and has completed one notable funding round. In March 2026, Maggu raised USD 4.

000 mn in SEED funding led by DGF Investments, with participation from IC Ventures, Norte Ventures, Latitud, and Airborne. Maggu AI specializes in an AI-driven support system designed specifically for pharmacies. Its main offering is an AI copilot that functions in real time at pharmacy counters, providing ongoing training and contextual guidance to pharmacy staff. This platform aids both new and experienced employees in making informed product recommendations, ultimately boosting their confidence and effectiveness during customer interactions.

Maggu's solution integrates seamlessly with existing pharmacy systems, without requiring changes to operations. Targeting primarily retail pharmacies in Brazil, the company addresses challenges in customer service and product recommendation accuracy, utilizing a database of over 200,000 medical leaflets and technical information that is regularly updated for compliance with current regulations. Maggu AI generates revenue through a subscription-based model in collaboration with pharmacies. Clients, ranging from pharmacy chains to independent stores, leverage Maggu’s services to improve operational efficiency and customer service quality.

The company delivers its offerings directly to these establishments, establishing itself as an essential component of the retail pharmacy ecosystem. This transaction structure is based on ongoing subscriptions for access to the Maggu platform, which includes training modules and real-time support features, allowing pharmacies to adopt the technology with minimal upfront investment. In March 2026, Maggu raised USD 4. 000 mn in SEED funding, led by DGF Investments, to expedite the adoption of its AI copilot within pharmacies and enhance its operational capacity for broader deployment across pharmacy networks.

The company aims to introduce new product features that improve the user experience, although specific product launch dates have not been disclosed. Expansion plans include targeting additional pharmacy markets outside of Brazil, with a focus on establishing a presence in Latin America by the end of 2026. The capital raised will accelerate these initiatives and support the expansion of the Maggu platform's capabilities.